Drug interactions
Peginterferon alfa 2a + Valoctocogene roxaparvovec
Severity: Moderate
Peginterferon alfa 2a and Valoctocogene roxaparvovec: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Valoctocogene roxaparvovec commonly causes elevated liver enzymes, and peginterferon alfa can also cause hepatotoxicity. Concurrent use may increase the risk of liver injury and may blunt the efficacy of gene therapy.
What this interaction means in plain words
Peginterferon alfa 2a and Valoctocogene roxaparvovec can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Peginterferon alfa 2a belongs to Anti Virals; Valoctocogene roxaparvovec belongs to Miscellaneous.
Why it happens
Additive hepatotoxicity.
What to do
Monitor ALT and other liver tests frequently after gene therapy and consider alternatives to hepatotoxic drugs. Interrupt peginterferon if liver enzymes rise significantly.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Peginterferon alfa 2a and Valoctocogene roxaparvovec, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Peginterferon alfa 2a
Other interactions of Valoctocogene roxaparvovec
Frequently asked questions
Can I take Peginterferon alfa 2a with Valoctocogene roxaparvovec?
MediHelp rates the interaction as moderate. Peginterferon alfa 2a and Valoctocogene roxaparvovec can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Valoctocogene roxaparvovec commonly causes elevated liver enzymes, and peginterferon alfa can also cause hepatotoxicity. Concurrent use may increase the risk of liver injury and may blunt the efficacy of gene therapy.
How serious is the interaction between Peginterferon alfa 2a and Valoctocogene roxaparvovec?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ALT and other liver tests frequently after gene therapy and consider alternatives to hepatotoxic drugs. Interrupt peginterferon if liver enzymes rise significantly.
What other medicines interact with Peginterferon alfa 2a?
MediHelp also lists interactions of Peginterferon alfa 2a with, for example, Clozapine, Deferiprone, Hydroxyurea. The full list is on the Peginterferon alfa 2a page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
